[Malignant hyperthermia--clinical aspects and treatment of life-endangering complications of anesthesia].
D000138:Acidosis / Q000139:chemically induced; D058186:Acute Kidney Injury / Q000139:chemically induced; D000768:Anesthesia, General / Q000009:adverse effects*; D001929:Brain Edema / Q000139:chemically induced; D002118:Calcium / Q000378:metabolism; D002463:Cell Membrane Permeability; D002648:Child; D003490:Cyanosis / Q000139:chemically induced; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced; D005260:Female; D006221:Halothane / Q000009:adverse effects; D006323:Heart Arrest / Q000139:chemically induced; D006801:Humans; D008305:Malignant Hyperthermia / Q000139:chemically induced* / Q000378:metabolism; D008733:Methoxyflurane / Q000009:adverse effects; D009127:Muscle Rigidity / Q000139:chemically induced; D011674:Pulse / Q000187:drug effects; D013390:Succinylcholine / Q000009:adverse effects
D008733:Methoxyflurane; D013390:Succinylcholine; D002118:Calcium; D006221:Halothane
Maligne Hyperthermie--Klinik und Therapie einer lebensbedrohlichen Narkosekomplikation